PubMed

Inhibition of experimental corneal neovascularisation by bevacizumab (Avastin).

Manzano RP, Peyman GA, Khan P, Carvounis PE, Kivilcim M, Ren M, Lake JC, Chévez-Barrios P.

Br J Ophthalmol. 2007 Jun;91(6):804-7. Epub 2006 Dec 19.PMID: 17179168 [PubMed - indexed for MEDLINE]Related articles

The effects of the subconjunctival injection of bevacizumab (Avastin) on angiogenesis in the rat cornea.

Barros LF, Belfort R Jr.

An Acad Bras Cienc. 2007 Sep;79(3):389-94.PMID: 17768531 [PubMed - indexed for MEDLINE]Related articlesFree article

The inhibitory effects of trastuzumab on corneal neovascularization.

Güler M, Yilmaz T, Ozercan I, Elkiran T.

Am J Ophthalmol. 2009 Apr;147(4):703-708.e2. Epub 2008 Dec 3.PMID: 19054498 [PubMed - indexed for MEDLINE]Related articles

Inhibition of experimental angiogenesis of cornea by various doses of doxycycline and combination of triamcinolone acetonide with low-molecular-weight heparin and doxycycline.

Aydin E, Kivilcim M, Peyman GA, Esfahani MR, Kazi AA, Sanders DR.

Cornea. 2008 May;27(4):446-53.PMID: 18434849 [PubMed - indexed for MEDLINE]Related articles

Prevention and treatment of corneal neovascularization: comparison of different doses of subconjunctival bevacizumab with corticosteroid in experimental rats.

Hashemian MN, Moghimi S, Kiumehr S, Riazi M, Amoli FA.

Ophthalmic Res. 2009;42(2):90-5. Epub 2009 Jun 18.PMID: 19546599 [PubMed - indexed for MEDLINE]Related articles

Inhibition of experimental corneal neovascularization by using subconjunctival injection of bevacizumab (Avastin).

Kim TI, Kim SW, Kim S, Kim T, Kim EK.

Cornea. 2008 Apr;27(3):349-52.PMID: 18362666 [PubMed - indexed for MEDLINE]Related articles

Effect of subconjunctival bevacizumab (Avastin) on experimental corneal neovascularization in guinea pigs.

Hurmeric V, Mumcuoglu T, Erdurman C, Kurt B, Dagli O, Durukan AH.

Cornea. 2008 Apr;27(3):357-62.PMID: 18362668 [PubMed - indexed for MEDLINE]Related articles

Bevacizumab inhibits corneal neovascularization in an alkali burn induced model of corneal angiogenesis.

Hosseini H, Nejabat M, Mehryar M, Yazdchi T, Sedaghat A, Noori F.

Clin Experiment Ophthalmol. 2007 Nov;35(8):745-8.PMID: 17997779 [PubMed - indexed for MEDLINE]Related articles

Subconjunctival injection of bevacizumab (avastin) on corneal neovascularization in different rabbit models of corneal angiogenesis.

Chen WL, Lin CT, Lin NT, Tu IH, Li JW, Chow LP, Liu KR, Hu FR.

Invest Ophthalmol Vis Sci. 2009 Apr;50(4):1659-65. Epub 2008 Nov 7.PMID: 18997093 [PubMed - indexed for MEDLINE]Related articles

Inhibition of corneal neovascularization by subconjunctival bevacizumab in an animal model.

Papathanassiou M, Theodossiadis PG, Liarakos VS, Rouvas A, Giamarellos-Bourboulis EJ, Vergados IA.

Am J Ophthalmol. 2008 Mar;145(3):424-431. Epub 2008 Jan 22.PMID: 18207123 [PubMed - indexed for MEDLINE]Related articles

Prevention of corneal neovascularization: evaluation of various commercially available compounds in an experimental rat model.

Riazi-Esfahani M, Peyman GA, Aydin E, Kazi AA, Kivilcim M, Sanders DR.

Cornea. 2006 Aug;25(7):801-5.PMID: 17068457 [PubMed - indexed for MEDLINE]Related articles

Bevacizumab (Avastin) eye drops inhibit corneal neovascularization.

Bock F, König Y, Kruse F, Baier M, Cursiefen C.

Graefes Arch Clin Exp Ophthalmol. 2008 Feb;246(2):281-4. Epub 2007 Oct 13.PMID: 17934753 [PubMed - indexed for MEDLINE]Related articles

Inhibition of corneal angiogenesis by ascorbic acid in the rat model.

Peyman GA, Kivilcim M, Morales AM, DellaCroce JT, Conway MD.

Graefes Arch Clin Exp Ophthalmol. 2007 Oct;245(10):1461-7. Epub 2007 Feb 21.PMID: 17318569 [PubMed - indexed for MEDLINE]Related articles

The effect of combinations of flurbiprofen, low molecular weight heparin, and doxycycline on the inhibition of corneal neovascularization.

Peyman GA, Kazi AA, Riazi-Esfahani M, Aydin E, Kivilcim M, Sanders DR.

Cornea. 2006 Jun;25(5):582-5.PMID: 16783147 [PubMed - indexed for MEDLINE]Related articles

Inhibition of corneal neovascularization by alpha(v)-integrin antagonists in the rat.

Klotz O, Park JK, Pleyer U, Hartmann C, Baatz H.

Graefes Arch Clin Exp Ophthalmol. 2000 Jan;238(1):88-93.PMID: 10664059 [PubMed - indexed for MEDLINE]Related articles

Safety, penetration and efficacy of topically applied bevacizumab: evaluation of eyedrops in corneal neovascularization after chemical burn.

Yoeruek E, Ziemssen F, Henke-Fahle S, Tatar O, Tura A, Grisanti S, Bartz-Schmidt KU, Szurman P; Tübingen Bevacizumab Study Group.

Acta Ophthalmol. 2008 May;86(3):322-8. Epub 2007 Nov 8.PMID: 17995975 [PubMed - indexed for MEDLINE]Related articles

Subconjunctival bevacizumab injection for corneal neovascularization.

Bahar I, Kaiserman I, McAllum P, Rootman D, Slomovic A.

Cornea. 2008 Feb;27(2):142-7.PMID: 18216566 [PubMed - indexed for MEDLINE]Related articles

The inhibitory effect of different concentrations of topical bevacizumab on corneal neovascularization.

Habot-Wilner Z, Barequet IS, Ivanir Y, Moisseiev J, Rosner M.

Acta Ophthalmol. 2009 Jun 22. [Epub ahead of print]PMID: 19549103 [PubMed - as supplied by publisher]Related articles

Inhibitory effects of bevacizumab on angiogenesis and corneal neovascularization.

Han YS, Lee JE, Jung JW, Lee JS.

Graefes Arch Clin Exp Ophthalmol. 2009 Apr;247(4):541-8. Epub 2008 Oct 25.PMID: 18953554 [PubMed - indexed for MEDLINE]Related articles

Effect of Octreotide on experimental corneal neovascularization.

Demir T, Celiker UO, Kükner A, Mogulkoç R, Celebi S, Celiker H.

Acta Ophthalmol Scand. 1999 Aug;77(4):386-90.PMID: 10463405 [PubMed - indexed for MEDLINE]Related articles